vaccine policy Archives

Business

Risk Premium Seen Behind Brent Crude’s Rise to $117

By Norman Pearlstine

Brent crude climbed to $117, near its yearly high, as analysts attribute the surge mainly to a risk premium linked to potential conflict rather than strong demand.

Comments closed

U.S. Halloween Candy Sales Slip 6.7% as Prices and Gas Costs Rise

By Mitchell Landsberg

Halloween candy sales fell 6.7% in the week ending Oct. 17, driven by higher gasoline costs and soaring chocolate prices, while small‑bag sales showed the only growth.

Comments closed

Volunteer converts emergency PHP patches into easy install packages

By Helene Elliott

Long‑time volunteer Ondřej Surý turned AI‑found PHP security fixes into ready‑to‑install packages, sparking a surge of donations and highlighting the reliance on open‑source maintainers.

Comments closed

SpaceX Talks Spark Rally in Tower Stocks, Drop in Carrier Shares

By Norman Pearlstine

Shares of tower owners jumped as SpaceX entered talks for 80,000 sites, while Verizon, AT&T and T‑Mobile slid sharply.

Comments closed

Moderna mRNA vaccine cuts melanoma recurrence risk by 42%

By Mitchell Landsberg

A personalized mRNA vaccine combined with pembrolizumab reduced the risk of melanoma returning or death by 42% in a phase III trial.

Comments closed

Science

Risk Premium Seen Behind Brent Crude’s Rise to $117

By Norman Pearlstine

Brent crude climbed to $117, near its yearly high, as analysts attribute the surge mainly to a risk premium linked to potential conflict rather than strong demand.

Comments closed

U.S. Halloween Candy Sales Slip 6.7% as Prices and Gas Costs Rise

By Mitchell Landsberg

Halloween candy sales fell 6.7% in the week ending Oct. 17, driven by higher gasoline costs and soaring chocolate prices, while small‑bag sales showed the only growth.

Comments closed

Volunteer converts emergency PHP patches into easy install packages

By Helene Elliott

Comments closed

SpaceX Talks Spark Rally in Tower Stocks, Drop in Carrier Shares

By Norman Pearlstine

Shares of tower owners jumped as SpaceX entered talks for 80,000 sites, while Verizon, AT&T and T‑Mobile slid sharply.

Comments closed

Moderna mRNA vaccine cuts melanoma recurrence risk by 42%

By Mitchell Landsberg

A personalized mRNA vaccine combined with pembrolizumab reduced the risk of melanoma returning or death by 42% in a phase III trial.

Comments closed